NH
Nancy Hong
OtherActiveManaging Director at RiverVest Venture Partners
San Diego, United StatesFounded 2014
41
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Nancy Hong.
Investment Thesis & Strategy
Nancy Hong, as Managing Director at RiverVest Venture Partners, invests in various stages of biotech, enterprise, health & hospital services, health IT, and pharmaceutical companies, seeking innovative solutions and strong growth potential.
Investment Activity
Deals per year over the last 1 years
1
2018Portfolio Companies
Selected investments from their portfolio of 41 companies
X
Xilio Therapeutics
Other · , 0
G
Good Therapeutics
Other · , 0
O
Otonomy
Other · , 0
L
Lumena Pharmaceuticals
Other · , 0
S
SeQure DX
Other · , 0
V
Velocimed
Other · , 0
C
Calypso Medical
Other · , 0
N
Neuros Medical
Other · , 0
L
Lyric Pharmaceuticals
Other · , 0
S
Scout Bio
Other · , 0
A
Avalyn Pharma
Other · , 0
M
Mirum Pharmaceuticals
Biotech · Series B, 2018
Frequently Asked Questions
Nancy Hong focuses on Seed, Pre-seed stage investments.